Gen Lin

1.5k total citations
64 papers, 537 citations indexed

About

Gen Lin is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Cancer Research. According to data from OpenAlex, Gen Lin has authored 64 papers receiving a total of 537 indexed citations (citations by other indexed papers that have themselves been cited), including 38 papers in Pulmonary and Respiratory Medicine, 37 papers in Oncology and 21 papers in Cancer Research. Recurrent topics in Gen Lin's work include Lung Cancer Treatments and Mutations (34 papers), Cancer Genomics and Diagnostics (12 papers) and Colorectal Cancer Treatments and Studies (11 papers). Gen Lin is often cited by papers focused on Lung Cancer Treatments and Mutations (34 papers), Cancer Genomics and Diagnostics (12 papers) and Colorectal Cancer Treatments and Studies (11 papers). Gen Lin collaborates with scholars based in China, United States and Hong Kong. Gen Lin's co-authors include Qian Miao, Kan Jiang, Haipeng Xu, Cheng Huang, Zhiyong He, Xiandong Lin, Dan Hu, Yunjian Huang, Weifeng Zhu and Yunbin Ye and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Gen Lin

54 papers receiving 530 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Gen Lin China 12 309 251 163 127 120 64 537
Angel Qin United States 12 343 1.1× 201 0.8× 178 1.1× 122 1.0× 94 0.8× 33 561
Takumi Yamaura Japan 13 329 1.1× 215 0.9× 200 1.2× 172 1.4× 156 1.3× 38 603
Ruixuan Geng China 12 254 0.8× 196 0.8× 234 1.4× 148 1.2× 66 0.6× 29 556
J.M. Sánchez-Torres Spain 13 614 2.0× 428 1.7× 150 0.9× 104 0.8× 99 0.8× 21 772
Luis Paz Ares Spain 7 462 1.5× 262 1.0× 188 1.2× 99 0.8× 154 1.3× 10 665
Santiago Ponce Aix Spain 15 620 2.0× 406 1.6× 165 1.0× 81 0.6× 150 1.3× 92 828
Julio A. Peguero United States 12 368 1.2× 241 1.0× 133 0.8× 78 0.6× 92 0.8× 49 517
Ivana Sullivan Spain 14 509 1.6× 322 1.3× 218 1.3× 100 0.8× 50 0.4× 55 686
Delphine Topart France 12 425 1.4× 234 0.9× 122 0.7× 231 1.8× 85 0.7× 29 606
Riccardo Ricotta Italy 13 307 1.0× 192 0.8× 165 1.0× 141 1.1× 37 0.3× 37 511

Countries citing papers authored by Gen Lin

Since Specialization
Citations

This map shows the geographic impact of Gen Lin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gen Lin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gen Lin more than expected).

Fields of papers citing papers by Gen Lin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gen Lin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gen Lin. The network helps show where Gen Lin may publish in the future.

Co-authorship network of co-authors of Gen Lin

This figure shows the co-authorship network connecting the top 25 collaborators of Gen Lin. A scholar is included among the top collaborators of Gen Lin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gen Lin. Gen Lin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lin, Gen, Yongsheng Wang, Tao Xin, et al.. (2025). Chinese Expert Consensus on Leptomeningeal Metastases of Lung Cancer. Thoracic Cancer. 16(11). e70088–e70088.
2.
Lin, Gen, et al.. (2025). “Dr. Jekyll and Mr. Hyde”: AT2 Cells in Lung Regeneration and Tumor Development. Cancer Research. 85(10). 1753–1754. 2 indexed citations
3.
Hong, Yaping, Haipeng Xu, Qin Shi, et al.. (2024). Plasma EGFR mutation ctDNA dynamics in patients with advanced EGFR-mutated NSCLC treated with Icotinib: phase 2 multicenter trial result. Scientific Reports. 14(1). 23115–23115. 3 indexed citations
4.
Jiang, Kan, Lin Wu, Yiquan Xu, et al.. (2024). Chemotherapy versus personalized therapy for EGFR mutant lung adenocarcinoma resistance to EGFR-tyrosine kinase inhibitors: a retrospective dual-center study. BMC Pulmonary Medicine. 24(1). 96–96. 1 indexed citations
5.
Hao, Yue, et al.. (2024). The influence of PD-L1 expression levels on the efficacy of combination therapy in thymic epithelial tumors. Clinical & Translational Oncology. 27(2). 542–548.
6.
Zhou, Qing, Yi‐Long Wu, Jianping Li, et al.. (2023). 658MO Phase I study of SHR-A2009, a HER3-targeted ADC, in advanced solid tumors. Annals of Oncology. 34. S463–S463. 6 indexed citations
7.
Miao, Qian, Lifeng Li, Xiaobin Zheng, et al.. (2023). Cerebrospinal fluid circulating tumor DNA contributes to the detection and characterization of leptomeningeal metastasis in non-small cell lung cancer. Journal of Neuro-Oncology. 165(3). 517–525. 5 indexed citations
8.
Hong, Yaping, Qian Miao, Yiquan Xu, et al.. (2023). Effects of intrathecal pemetrexed on the survival of patients with leptomeningeal metastasis from lung adenocarcinoma: a propensity score matching analysis. Journal of Neuro-Oncology. 165(2). 301–312. 4 indexed citations
9.
Zeng, Chen, Xingguang Luο, Ying Su, et al.. (2022). Hsa_circ_0006692 Promotes Lung Cancer Progression via miR-205-5p/CDK19 Axis. Genes. 13(5). 846–846. 12 indexed citations
10.
Wang, Wenxian, Gen Lin, Yue Hao, et al.. (2022). Treatment outcomes and prognosis of immune checkpoint inhibitors therapy in patients with advanced thymic carcinoma: A multicentre retrospective study. European Journal of Cancer. 174. 21–30. 10 indexed citations
11.
Lu, Tao, Kan Jiang, Longfeng Zhang, et al.. (2022). Tumour response heterogeneity as a powerful independent predictor of treatment outcome in advanced lung adenocarcinoma: a retrospective analysis. The Lancet Oncology. 23. S13–S13. 1 indexed citations
12.
Lu, Tao, Longfeng Zhang, Mingqiu Chen, et al.. (2021). Intrapulmonic Cavity or Necrosis on Baseline CT Scan Serves as an Efficacy Predictor of Anti-PD-(L)1 Inhibitor in Advanced Lung Squamous Cell Carcinoma. Cancer Management and Research. Volume 13. 5931–5939. 1 indexed citations
13.
Miao, Qian, Longfeng Zhang, Xiaobin Zheng, et al.. (2021). Transformation of a cold to hot tumor and a durable response to immunotherapy in a patient with non-small cell lung cancer after chemoradiotherapy: a case report. Annals of Palliative Medicine. 10(4). 4982–4986. 4 indexed citations
14.
Zhao, Jun, Gen Lin, Minglei Zhuo, et al.. (2019). Next-generation sequencing based mutation profiling reveals heterogeneity of clinical response and resistance to osimertinib. Lung Cancer. 141. 114–118. 30 indexed citations
15.
Lin, Gen, Jun Zhao, Jinliang Kong, et al.. (2019). P2.14-09 Concurrent TP53 Mutation Adversely Impact the Efficacy of Crizotinib in ROS1-Rearranged Lung Cancer Patients. Journal of Thoracic Oncology. 14(10). S832–S832. 2 indexed citations
16.
Lin, Gen, Chao Li, Cheng Huang, et al.. (2018). Co‐expression of NF‐κB‐p65 and phosphorylated NF‐κB‐p105 is associated with poor prognosis in surgically resectable non‐small cell lung cancer. Journal of Cellular and Molecular Medicine. 22(3). 1923–1930. 11 indexed citations
17.
Yuan, Mei, et al.. (2018). P1.01-105 Lung Cancer Patients with Concurrent EGFR and MET Mutations: A Retrospective Analysis of 29 Cases. Journal of Thoracic Oncology. 13(10). S504–S504.
18.
Xu, Haipeng, Gen Lin, Cheng Huang, et al.. (2017). Assessment of Concordance between 22C3 and SP142 Immunohistochemistry Assays regarding PD-L1 Expression in Non-Small Cell Lung Cancer. Scientific Reports. 7(1). 16956–16956. 36 indexed citations
19.
Li, Chao, Cheng Huang, Tony Mok, et al.. (2017). Comparison of 22C3 PD-L1 Expression between Surgically Resected Specimens and Paired Tissue Microarrays in Non–Small Cell Lung Cancer. Journal of Thoracic Oncology. 12(10). 1536–1543. 46 indexed citations
20.
Chen, Yu, Gen Lin, Zengqing Guo, et al.. (2013). Effects of MICA Expression on the Prognosis of Advanced Non-Small Cell Lung Cancer and the Efficacy of CIK Therapy. PLoS ONE. 8(7). e69044–e69044. 40 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Angel Qin Breakdown of academic impact, for papers by Takumi Yamaura Breakdown of academic impact, for papers by Ruixuan Geng Breakdown of academic impact, for papers by J.M. Sánchez-Torres Breakdown of academic impact, for papers by Luis Paz Ares Breakdown of academic impact, for papers by Santiago Ponce Aix Breakdown of academic impact, for papers by Julio A. Peguero Breakdown of academic impact, for papers by Ivana Sullivan Breakdown of academic impact, for papers by Delphine Topart Breakdown of academic impact, for papers by Riccardo Ricotta
Rankless by CCL
2026